ORMP
Oramed Pharmaceuticals IncNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage ready
Factor tilt: Quality-tilted Micro Cap
$4.17-2.34%
Close Oct 13, 2026
- Market cap
- $170.66M
- 1 month
- -10.7%
- 3 months
- +2.7%
- 1 year
- +73.0%
- 52-week range
- $2.19$5.34
- Dividend
- No payments on record
- Short interest
- 4.5% of float1.4M shares · settled Sep 30, 2026 · +9.6% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- $174.87M
- Free cash flow
- -$5.37M
- Book value
- $317.47M
- Total debt
- $733K
- P/E
- 1×
- Price / sales
- —
- Price / book
- 0.5×
- FCF yield
- -3.1%
- Net margin
- —
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ORMP is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
16 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: sell 13 days ago
Red flags: 5
Largest 13-F holders · Q2 2026
84 filers reported a long position in ORMP for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MERCER GLOBAL ADVISORS INC /ADV | $18.3M | 3.8M | +99.4% |
| Aquamarine Financial (Cayman) Ltd | $12.1M | 2.5M | +18.9% |
| Gem Investment Advisors, LLC | $9.6M | 2M | +21.9% |
| BlackRock, Inc. | $7.7M | 1.6M | +1,644.3% |
| Murchinson Ltd. | $6.2M | 1.3M | -1.9% |
| BML Capital Management, LLC | $4.2M | 866.3K | -72.6% |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.8M | 578.6K | -3.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $2.4M | 500.7K | +1,962% |
| GOLDMAN SACHS GROUP INC | $1.2M | 253.3K | New |
| STATE STREET CORP | $1.2M | 242.1K | New |
Get the Full Analysis for ORMP
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.